Based in Germany, DynamoBio AG is a startup. Brouky records 1 investor associated with the company.
DynamoBio AG develops advanced biotechnological solutions that aim to more accurately model human biology for therapeutics development, moving beyond traditional animal-based systems to improve prediction of human disease and treatment outcomes.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.